Heleos Advisors

Heleos Advisors is a strategic advisory firm and company builder focused on the life sciences industry. The firm provides expert consultancy in corporate strategy, business development, and portfolio management, led by a team of former senior executives from companies such as AstraZeneca, Takeda, and Akebia. In addition to its advisory services, the firm operates Heleos, Inc., a biotechnology company dedicated to developing targeted antimicrobial therapies to address multi-drug resistant infections. Heleos, Inc.'s lead programs include C-Scape, a combination therapy for complicated urinary tract infections acquired from Achaogen, and HLOS-001, a preclinical program targeting Acinetobacter baumannii. The firm leverages its deep industry expertise to identify and develop high-value assets while providing strategic guidance to external clients.